{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:50:16Z","timestamp":1762530616237,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.adro.2023.101290","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T21:47:10Z","timestamp":1686606430000},"page":"101290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elective Nodal Irradiation for Oligorecurrent Nodal Prostate Cancer: Interobserver Variability in the PEACE V-STORM Randomized Phase 2 Trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Orane","family":"Lorton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-8851","authenticated-orcid":false,"given":"V\u00e9rane","family":"Achard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Koutsouvelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maud","family":"Jaccard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Vanhoutte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Dipasquale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Ost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2023.101290_bib0001","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1080\/0284186X.2020.1775291","article-title":"Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: A systematic review","volume":"59","author":"Achard","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.adro.2023.101290_bib0002","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12885-020-06911-4","article-title":"PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): A study protocol for a randomized controlled phase II trial","volume":"20","author":"De Bruycker","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.adro.2023.101290_bib0003","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.euf.2020.12.010","article-title":"The multicenter, randomized, phase 2 PEACE V-STORM trial: Defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases","volume":"7","author":"Zilli","year":"2021","journal-title":"Eur Urol Focus. Mar"},{"key":"10.1016\/j.adro.2023.101290_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2022.04.020","article-title":"Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial","volume":"172","author":"Achard","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101290_bib0005","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ijrobp.2014.08.348","article-title":"Global harmonization of quality assurance naming conventions in radiation therapy clinical trials","volume":"90","author":"Melidis","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101290_bib0006","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijrobp.2008.08.002","article-title":"RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer","volume":"74","author":"Lawton","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101290_bib0007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.eururo.2016.07.043","article-title":"Patterns of lymph node failure after dose-escalated radiotherapy: Implications for extended pelvic lymph node coverage","volume":"71","author":"Spratt","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2023.101290_bib0008","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1748-717X-9-135","article-title":"Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence","volume":"9","author":"Decaestecker","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101290_bib0009","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1109\/TPAMI.2015.2408351","article-title":"An efficient algorithm for calculating the exact Hausdorff distance","volume":"37","author":"Taha","year":"2015","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"10.1016\/j.adro.2023.101290_bib0010","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.20.03282","article-title":"Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): Outcomes from phase III randomized controlled trial","volume":"39","author":"Murthy","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2023.101290_bib0011","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology\/RTOG 0534 SPPORT): An international, multicentre, randomised phase 3 trial","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2023.101290_bib0012","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijrobp.2020.08.034","article-title":"NRG oncology updated international consensus atlas on pelvic lymph node volumes for intact and postoperative prostate cancer","volume":"109","author":"Hall","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101290_bib0013","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.eururo.2018.10.044","article-title":"Nodal oligorecurrent prostate cancer: Anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates","volume":"75","author":"De Bruycker","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2023.101290_bib0014","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00259-017-3746-9","article-title":"Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after (68)Ga-PSMA-PET imaging","volume":"44","author":"Schiller","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.adro.2023.101290_bib0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2967\/jnumed.117.201749","article-title":"(68)Ga-PSMA-11 PET\/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng\/mL: Impact on salvage radiotherapy planning","volume":"59","author":"Calais","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.adro.2023.101290_bib0016","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ijrobp.2015.03.021","article-title":"Consensus guidelines and contouring atlas for pelvic node delineation in prostate and pelvic node intensity modulated radiation therapy","volume":"92","author":"Harris","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101290_bib0017","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ijrobp.2016.06.2455","article-title":"Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Update of the long-term survival results of the GETUG-01 randomized study","volume":"96","author":"Pommier","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101290_bib0018","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S1470-2045(18)30528-X","article-title":"Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG\/RTOG 9413): Long-term results of a randomised, phase 3 trial","volume":"19","author":"Roach","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2023.101290_bib0019","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1016\/S1470-2045(21)00242-4","article-title":"Elective nodal radiotherapy in prostate cancer","volume":"22","author":"De Meerleer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2023.101290_bib0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.eururo.2019.04.016","article-title":"Have we entered the era of imaging before salvage treatment for recurrent prostate cancer?","volume":"76","author":"Devos","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2023.101290_bib0021","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.prro.2017.10.005","article-title":"Bowel and urinary quality of life after whole-pelvic versus prostate-only volumetric-modulated arc therapy for localized prostate cancer","volume":"8","author":"Ishii","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101290_bib0022","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.radonc.2017.07.005","article-title":"Patient-reported intestinal toxicity from whole pelvis intensity-modulated radiotherapy: First quantification of bowel dose-volume effects","volume":"124","author":"Sini","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101290_bib0023","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41585-019-0213-3","article-title":"New approaches for effective and safe pelvic radiotherapy in high-risk prostate cancer","volume":"16","author":"Tharmalingam","year":"2019","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.adro.2023.101290_bib0024","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijrobp.2018.10.003","article-title":"Toxicity and patient-reported outcomes of a phase 2 randomized trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)","volume":"103","author":"Dearnaley","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101290_bib0025","first-page":"10","article-title":"A deep learning-based automated CT segmentation of prostate cancer anatomy for radiation therapy planning-a retrospective multicenter study","author":"Kiljunen","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.adro.2023.101290_bib0026","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2019.11.004","article-title":"Systematic review of educational interventions to improve contouring in radiotherapy","volume":"144","author":"Cacicedo","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101290_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150917","article-title":"Harmonization of the volume of interest delineation among all eleven radiotherapy centers in the north of France","volume":"11","author":"Pasquier","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.adro.2023.101290_bib0028","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canrad.2018.03.007","article-title":"Harmonization of practices between radiotherapy centres in the Nord and Pas-de-Calais regions (France): A three-year evaluation","volume":"23","author":"Pasquier","year":"2019","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.adro.2023.101290_bib0029","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ijrobp.2021.05.009","article-title":"Validating modern NRG Oncology pelvic nodal and Groupe Francophone de Radiotherapie Urologique prostate bed contouring guidelines for post-prostatectomy salvage radiation: A secondary analysis of the LOCATE trial","volume":"111","author":"Harmon","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101290_bib0030","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.euo.2022.09.006","article-title":"Prostate-specific membrane antigen positron emission tomography\/computed tomography-based lymph node atlas for salvage radiotherapy in patients with recurrent prostate cancer: A validation of the new NRG Oncology 2020 guideline","volume":"5","author":"Vogel","year":"2022","journal-title":"Eur Urol Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109423001197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109423001197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:44:08Z","timestamp":1762530248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109423001197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2452109423001197"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2023.101290","relation":{},"ISSN":["2452-1094"],"issn-type":[{"type":"print","value":"2452-1094"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elective Nodal Irradiation for Oligorecurrent Nodal Prostate Cancer: Interobserver Variability in the PEACE V-STORM Randomized Phase 2 Trial","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2023.101290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101290"}}